• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care.

作者信息

Lippi Giuseppe, Mattiuzzi Camilla, Favaloro Emmanuel J

机构信息

1U.O. Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci, 14, 43126 - Parma, Italy2Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy.

3Service of Service of Clinical Governance, General Hospital of Trento, Trento, Italy.

出版信息

Diagnosis (Berl). 2014 Dec 1;1(4):311-312. doi: 10.1515/dx-2014-0054.

DOI:10.1515/dx-2014-0054
PMID:29540010
Abstract
摘要

相似文献

1
Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care.正在服用直接口服抗凝剂的患者的血栓形成倾向检测。小心处理。
Diagnosis (Berl). 2014 Dec 1;1(4):311-312. doi: 10.1515/dx-2014-0054.
2
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.达比加群、利伐沙班和阿哌沙班治疗心房颤动的间接比较。
Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28.
3
Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.非瓣膜性心房颤动患者口服抗凝药的持续性：一项使用德国初级保健数据的队列研究。
PLoS One. 2017 Oct 10;12(10):e0185642. doi: 10.1371/journal.pone.0185642. eCollection 2017.
4
Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.非维生素K拮抗剂口服抗凝药在心血管疾病管理中的应用：证据与未解决的问题
J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3.
5
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.低剂量非维生素K拮抗剂口服抗凝药与华法林在房颤患者中的有效性和安全性：倾向评分加权的全国队列研究
BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.
6
Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum.超高效液相色谱-紫外法测定人血清中直接口服抗凝剂：阿哌沙班、利伐沙班、达比加群及其前体药物达比加群酯的方法开发
Ther Drug Monit. 2017 Feb;39(1):66-76. doi: 10.1097/FTD.0000000000000355.
7
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.新型口服抗凝药物在预防心房颤动卒中方面的疗效和安全性的间接比较。
J Am Coll Cardiol. 2012 Aug 21;60(8):738-46. doi: 10.1016/j.jacc.2012.03.019. Epub 2012 May 9.
8
The use of direct oral anticoagulants in inherited thrombophilia.直接口服抗凝剂在遗传性血栓形成倾向中的应用。
J Thromb Thrombolysis. 2017 Jan;43(1):24-30. doi: 10.1007/s11239-016-1428-2.
9
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.阿哌沙班与其他新型口服抗凝药预防心房颤动卒中的成本效益比较。
Clin Ther. 2014 Feb 1;36(2):192-210.e20. doi: 10.1016/j.clinthera.2013.12.011. Epub 2014 Feb 6.
10
Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.采用湍流液相色谱-高分辨率质谱法测定人血浆中直接口服抗凝剂阿哌沙班、达比加群、依度沙班和利伐沙班。
Ther Drug Monit. 2014 Oct;36(5):597-605. doi: 10.1097/FTD.0000000000000059.

引用本文的文献

1
Stroke Thrombectomy and Right Atrial Clot Aspiration in 29 Year Old Woman.29岁女性的中风血栓切除术及右心房血块抽吸术
Neurohospitalist. 2024 Jan;14(1):95-98. doi: 10.1177/19418744231200052. Epub 2023 Sep 1.
2
Laboratory Evaluation of Thrombophilia.血栓形成倾向的实验室评估。
Methods Mol Biol. 2023;2663:177-201. doi: 10.1007/978-1-0716-3175-1_10.
3
Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing - Evaluation on spiked and patient samples.通过直接口服抗凝剂（DOAC）过滤器去除直接口服抗凝剂：对狼疮抗凝物检测的影响——对加标样本和患者样本的评估
Res Pract Thromb Haemost. 2022 Mar 21;6(2):e12633. doi: 10.1002/rth2.12633. eCollection 2022 Feb.
4
Thrombophilia testing in the era of direct oral anticoagulants.直接口服抗凝剂时代的血栓形成倾向检测。
Clin Med (Lond). 2021 Sep;21(5):e487-e491. doi: 10.7861/clinmed.2020-1008. Epub 2021 Sep 7.
5
Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests.评估DOAC-Stop®程序以克服直接口服抗凝剂（DOACs）对多项血栓形成倾向筛查试验的影响。
TH Open. 2018 Jun 1;2(2):e202-e209. doi: 10.1055/s-0038-1657785. eCollection 2018 Apr.
6
Primary Thrombophilia in México XI: Activated Protein C Resistance Phenotypes are Multifactorial.墨西哥原发性血栓形成倾向研究之十一：活化蛋白C抵抗表型是多因素的。
Indian J Hematol Blood Transfus. 2017 Sep;33(3):375-379. doi: 10.1007/s12288-016-0767-7. Epub 2016 Dec 19.
7
Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives.直接口服抗凝剂对止血检测的干扰：诊断出现假阳性和假阴性的可能性很大。
Blood Transfus. 2017 Oct;15(6):491-494. doi: 10.2450/2017.0301-16. Epub 2017 Mar 7.